These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7851453)

  • 21. The interaction between depressive affective disorder and neuropsychological test performance in multiple sclerosis patients.
    Schiffer RB; Caine ED
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):28-32. PubMed ID: 7580169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
    Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures.
    Gold SM; Schulz H; Mönch A; Schulz KH; Heesen C
    Mult Scler; 2003 Aug; 9(4):404-10. PubMed ID: 12926847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating Neurocognitive Deficits in Patients With Multiple Sclerosis Via a Brief Neuropsychological Approach.
    Davis A; Williams RN; Gupta AS; Finch WH; Randolph C
    Appl Neuropsychol Adult; 2015; 22(5):381-7. PubMed ID: 25729879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression, disability and cognitive impairment in multiple sclerosis: a cross sectional Italian study.
    Mattioli F; Bellomi F; Stampatori C; Parrinello G; Capra R
    Neurol Sci; 2011 Oct; 32(5):825-32. PubMed ID: 21594654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory impairment in multiple sclerosis.
    Minden SL; Moes EJ; Orav J; Kaplan E; Reich P
    J Clin Exp Neuropsychol; 1990 Aug; 12(4):566-86. PubMed ID: 2211978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive impairment after three decades of multiple sclerosis.
    Smestad C; Sandvik L; Landrø NI; Celius EG
    Eur J Neurol; 2010 Mar; 17(3):499-505. PubMed ID: 20050887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of neuropsychological treatment in patients with multiple sclerosis.
    Jønsson A; Korfitzen EM; Heltberg A; Ravnborg MH; Byskov-Ottosen E
    Acta Neurol Scand; 1993 Dec; 88(6):394-400. PubMed ID: 8116338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment in Behçet's disease patients without overt neurological involvement.
    Monastero R; Camarda C; Pipia C; Lopez G; Camarda LK; Baiamonte V; Ferrante A; Triolo G; Camarda R
    J Neurol Sci; 2004 May; 220(1-2):99-104. PubMed ID: 15140614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of cognitive impairment in a community survey of multiple sclerosis.
    McIntosh-Michaelis SA; Roberts MH; Wilkinson SM; Diamond ID; McLellan DL; Martin JP; Spackman AJ
    Br J Clin Psychol; 1991 Nov; 30(4):333-48. PubMed ID: 1777755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of early cognitive impairment in patients with clinically isolated syndromes and multiple sclerosis.
    Baysal Kıraç L; Ekmekçi Ö; Yüceyar N; Sağduyu Kocaman A
    Behav Neurol; 2014; 2014():637694. PubMed ID: 25944978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cognitive functions in multiple sclerosis].
    Vicens A; Iriarte J; de Castro P; Castejón C; Martínez-Lage JM
    Neurologia; 1992; 7(7):171-5. PubMed ID: 1419085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression.
    Daly E; Komaroff AL; Bloomingdale K; Wilson S; Albert MS
    Appl Neuropsychol; 2001; 8(1):12-22. PubMed ID: 11388119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.
    Nunnari D; De Cola MC; D'Aleo G; Rifici C; Russo M; Sessa E; Bramanti P; Marino S
    Biomed Res Int; 2015; 2015():519785. PubMed ID: 25861633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.
    Polychroniadou E; Bakirtzis C; Langdon D; Lagoudaki R; Kesidou E; Theotokis P; Tsalikakis D; Poulatsidou K; Kyriazis O; Boziki M; Papadopoulos G; Boura E; Sintila L; Hatzigeorgiou S; Ziamos C; Ioannidis P; Karacostas D; Grigoriadis N
    Mult Scler Relat Disord; 2016 Sep; 9():68-72. PubMed ID: 27645348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.